UCLB spinout Orchard Therapeutics has announced the pricing of its initial public offering in the United States of 14,285,715 American Depositary Shares (“ASDs” [...]
UCLB spinout Endomag, the surgical guidance company, has won a prestigious British Business Innovation Award from the Institute of Physics (IOP), presented at t [...]
UCLTF investment manager David Grimm recently spoke to Global University Venturing editor Thierry Heles to explain more about how the Fund is investing in UCL t [...]
Having spent 30 years at UCL, 25 of those at UCLB, Cengiz Tarhan announces his intention to retire, stepping down from his role as Managing Director of UCLB at [...]
Today we are pleased to launch our new logo and branding. This new look will take UCLB on to the next 25 years of successfully commercialising technology at UCL [...]
Data anonymisation software developer, Hazy gained coverage in The Telegraph’s Technology Intelligence pages, in light of the $1.8m it has raised in seed fundin [...]
UCLB spinout company, Endomagnetics Ltd, who are developing a portfolio of products to improve the standard of breast cancer management, announced they have rai [...]
Thursday the 5th July saw UCLB host its annual summer reception event, celebrating some of the remarkable achievements of the UCL spinout companies and ground-b [...]
Three UCL spin-out companies focused on delivering advanced therapeutics to treat a range of diseases received a substantial amount of investment following two [...]
UCL spin-out Matrix Mill Ltd, a company specialising in applying artificial intelligence and machine vision research to solve industry problems, has been acquir [...]
